ETC-1001

Thuốc Gốc

Small Molecule

ETC-1001 is Pfizer’s lead oral small molecule product candidate which is intended to be a chronic treatment for individuals with lipid disorders.

Cơ Chế Tác Dụng : ETC-1001 is Pfizer’s lead oral small molecule product candidate which is intended to be a chronic treatment for individuals with lipid disorders. ETC-1001 is a synthetic, orally-active lipid regulating agent designed to elevate levels of high-density lipoprotein cholesterol (HDL-C), the "good" cholesterol. In pre-clinical studies, it shows the ability to elevate HDL-cholesterol levels, while also reducing levels of low-density lipoprotein cholesterol (LDL-C), the "bad" cholesterol, and triglycerides. It also inhibits the progression of atherosclerosis in pre- clinical models.

Chỉ Định : Investigated for use/treatment in hyperlipidemia.

Tài Liệu Tham Khảo Thêm

drugbank

http://www.drugbank.ca/drugs/DB05866

Bạn thấy hài lòng ?

Bạn chưa hài lòng ?

... loading